Koster H, Halsema I, Scholtens E, Pang K S, Mulder G J
Biochem Pharmacol. 1982 Oct 1;31(19):3023-8. doi: 10.1016/0006-2952(82)90074-0.
Harmol is conjugated by glucuronidation and sulfation when it is given to the rat in vivo. In the once-through perfused rat liver preparation glucuronidation of harmol shows kinetic aberrances [Pang et al., J. Pharmac. exp. Ther. 219, 134 (1981)]. In order to further delineate the mechanism behind this, sulfation was inhibited to about 10% of control by 2,6-dichloro-4-nitrophenol. The loss of sulfation was compensated by an increase in the rate of glucuronidation, keeping the total clearance by the liver virtually constant in spite of the loss of sulfation. The inhibition of sulfation eliminated the previously observed lag-phase in the kinetics of glucuronidation; the rate of glucuronidation was now almost linear with the input concentration of the substrate harmol. The constant clearance of harmol in spite of inhibition of sulfation, the occurrence of the lag-phase in glucuronidation in the presence of sulfation, and the disappearance of this lag-phase in the absence of sulfation can be explained by either diffusion-limited metabolism of harmol or a heterogeneous sub-lobular distribution of the sulfating and glucuronidating systems. Activation of glucuronidation by harmol at high concentration can be excluded.
哈尔莫在体内给予大鼠时会通过葡萄糖醛酸化和硫酸化进行结合。在一次性灌注大鼠肝脏制备物中,哈尔莫的葡萄糖醛酸化表现出动力学异常[庞等人,《药理学与实验治疗学杂志》219, 134 (1981)]。为了进一步阐明其背后的机制,用2,6 - 二氯 - 4 - 硝基苯酚将硫酸化抑制至对照的约10%。硫酸化的损失通过葡萄糖醛酸化速率的增加得到补偿,尽管硫酸化有所损失,但肝脏的总清除率实际上保持恒定。硫酸化的抑制消除了先前在葡萄糖醛酸化动力学中观察到的滞后阶段;现在葡萄糖醛酸化速率与底物哈尔莫的输入浓度几乎呈线性关系。尽管硫酸化受到抑制,但哈尔莫的清除率保持恒定,在存在硫酸化时葡萄糖醛酸化出现滞后阶段,而在不存在硫酸化时该滞后阶段消失,这可以通过哈尔莫的扩散限制代谢或硫酸化和葡萄糖醛酸化系统的小叶下不均匀分布来解释。高浓度哈尔莫对葡萄糖醛酸化的激活可以排除。